Carregant...
Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation
Nowadays, minimal residual disease (MRD) is accepted as the strongest independent prognostic factor in acute lymphoblastic leukemia (ALL). It can be detected by molecular methods that use leukemia-specific or patient-specific molecular markers (fusion gene transcripts, or immunoglobulin/T-cell recep...
Guardat en:
| Publicat a: | Blood Adv |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5729622/ https://ncbi.nlm.nih.gov/pubmed/29296895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009845 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|